A Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Acarbose Added on Top of Metformin and Sitagliptin Combination Treatment in Type 2 Diabetes Mellitus Patients.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Acarbose (Primary) ; Metformin; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ACADEMIC
- 17 Aug 2020 Biomarkers information updated
- 19 Feb 2013 Planned end date changed from 1 Jun 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 16 Dec 2011 New trial record